Archrock is trading at approximately $33.60 (down 6%) after reporting Q2 2026 results that missed Wall Street expectations and tightening its full-year guidance.
- Revenue declined year-over-year and came in below consensus estimates, while earnings per share (EPS) also missed analyst forecasts.
- Management lowered the high end of its 2026 Adjusted EBITDA guidance range, pressuring the stock despite broader market strength.